Page Menu

Advisory Committee

The Center Advisory Committee (CAC) was established by the CRC's Director and co-Director and approved by NIH program officials. The current CAC is comprised of eight members with scientific and clinical expertise and includes patient advocate representation. None of the CAC members are investigators in this Center.

UMMS Wellstone Center Advisory Committee (2014)

Michael R. Altherr, Ph.D.
BioScience Division
Group B-5
Mail Stop M888
Los Alamos National Laboratory
Los Alamos, NM 87545
Expert in FSHD and human genetics

Haig Kazazian, M.D.
Professor of Human Genetics
Johns Hopkins University School of Medicine
MRB 439
733 N. Broadway
Baltimore, MD  21205
Expert in human genetics, genome biology and transposable DNA elements

Elizabeth McNally, M.D., Ph.D.
AJ Carson Professor of Medicine & Human Genetics, 
Director Institute for Cardiovascular Researcher and Director, Cardiovascular Genetics Clinic
University of Chicago Medical Center
5841 S. Maryland Avenue, MC 6088
Chicago, IL 60637
Expert in muscular dystrophy, mouse models and genetics

Natalie Moss, A.M.
Chairman of Moss Capital
Founder of the FSHD Global Research Foundation Limited
FSHD Global Research Foundation Limited
PO Box A298
South NSW
Leader in FSHD patient advocacy

Terrance Partridge, Ph.D.
Associate Director, Children’s Research Institute 
Center for Genetic Medicine Research 
Children's National Medical Center 
111 Michigan Avenue, NW 
Washington, DC 20010-2970 
Expert in muscle regeneration and disease

Charles Thornton, M.D.
Professor, Department of Neurology
University of Rochester Medical School
School of Medicine and Dentistry 
601 Elmwood Ave, Box 645 
Rochester, NY 14642 
Expert in myotonic dystrophy and RNA therapeutics

Additional Resources
click to open search panel